BMRN vs DTCX · P/E 40, rev $1.76B vs rev $4.1M
Biomarin Pharmaceutical Inc (BMRN) versus Datacentrex, Inc. (DTCX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Datacentrex, Inc. (DTCX) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DTCX revenue for 2026-06-30 was $4.1M. Net income was -$11.6M. Revenue was up 87.8% from 2026-03-31 to 2026-06-30. DTCX currently screens at market cap $82.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DTCX currently screens at market cap $82.0M.
Not investment advice. Open the BMRN and DTCX stock pages for the full models.
Not investment advice.